This page shows the latest Regeneron news and features for those working in and with pharma, biotech and healthcare.
The US Food and Drug Administration (FDA) has accepted priority review of Sanofi and Regeneron’s jointly developed Dupixent (dupilumab) to treat adults with prurigo nodularis.
The National Institute for Health and Care Excellence (NICE) has recommended Sanofi and Regeneron’s Libtayo (cemiplimab) for patients with metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC).
Sanofi and Regeneron have received approval from the US Food and Drug Administration (FDA) for the use of Dupixent (dupilumab) as a treatment for patients with eosinophilic oesophagitis (EoE).
a promising new modality to Regeneron's toolkit of potential approaches for difficult-to-treat cancers. ... We look forward to welcoming the Checkmate team and their complementary scientific acumen to the Regeneron family.".
George Yancopoulos, president and chief scientific officer at Regeneron, said: “Today’s approval in Europe recognises the benefits of Dupixent in helping children living with the profound effects of severe asthma.
Previously, Sanofi and Regeneron announced topline results from PRIME2 and a second trial called PRIME, investigating the use of Dupixent in adults with uncontrolled prurigo nodularis.
More from news
Approximately 96 fully matching, plus 187 partially matching documents found.
The same approach may work against SARSCoV-2. Regeneron Pharmaceuticals, leveraging a platform that spawned an Ebola treatment, is leading efforts to show that antibodies can neutralise SARS-CoV-2. ... A clinical trial of Regeneron’s drug is scheduled
Evaluating IL-6 inhibitors: Roche’s Actemra and Sanofi and Regeneron’s Kevzara. Roche, Sanofi and Regeneron are also looking to repurpose their existing treatments and are currently testing their ... 19,” said George D Yancopoulos, co-founder,
The changes also mean Sanofi has downgraded some long-standing relationship in R&D – such as a fruitful tie-up with Regeneron that generated some of its top-selling drugs like ... Analysts think the deal could catapult Galapagos into the top tier of
Client:Sanofi Genzyme and Regeneron. Agency:Havas Lynx Group. Campaign:See Below. Timescale:N/A. Atopic dermatitis affects approximately 1-3% of adults worldwide. ... Topical corticosteroids are commonly used to treat atopic dermatitis. Sanofi Genzyme
Innovation in Healthcare Communications. One high profile winning campaign was Havas Lynx Group’s ‘See Below’ on behalf of Sanofi Genzyme and Regeneron.
More from intelligence
Approximately 1 fully matching, plus 19 partially matching documents found.
Prior to this, Dr Evans held a number of scientific leadership positions while at Amgen, Johnson &Johnson and Regeneron.
Robert Landry succeeds Murray Goldberg. Former Pfizer senior VP Robert Landry has joined Regeneron as senior VP, finance, and will later take over as chief financial officer. ... We are extremely fortunate that Murray will stay at Regeneron through 2014
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Sandra Graham-Mason, Director of Marketing at Regeneron Pharmaceuticals discusses a variety of topics, from the impact of COVID-19 on the way that Pharma teams interact with internal stakeholders and
Shire/Takeda. Pfizer. Amgen. Regeneron.
More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.
Hello. We are the Total Health creative agency. It’s our collective mix of talent that gets us to truly different...